2020
DOI: 10.1038/s41388-020-01500-y
|View full text |Cite
|
Sign up to set email alerts
|

SIX4 promotes hepatocellular carcinoma metastasis through upregulating YAP1 and c-MET

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
27
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 37 publications
(27 citation statements)
references
References 53 publications
0
27
0
Order By: Relevance
“…YAP1 is in hyperactive status and considered to be an oncogene in several types of solid tumors, including HCC ( 19 ). SIX4 promotes hepatocellular carcinoma metastasis through upregulating YAP1 ( 20 ). LncRNA B4GALT1-AS1 facilitates colon cancer cell stemness via recruiting YAP1 to the nucleus and enhancing YAP1 transcriptional activity ( 21 ).…”
Section: Introductionmentioning
confidence: 99%
“…YAP1 is in hyperactive status and considered to be an oncogene in several types of solid tumors, including HCC ( 19 ). SIX4 promotes hepatocellular carcinoma metastasis through upregulating YAP1 ( 20 ). LncRNA B4GALT1-AS1 facilitates colon cancer cell stemness via recruiting YAP1 to the nucleus and enhancing YAP1 transcriptional activity ( 21 ).…”
Section: Introductionmentioning
confidence: 99%
“…SIX4 expression has been detected in non-small cell lung ( Tang et al, 2019 ), breast ( Sun et al, 2020 ), colorectal ( Li et al, 2017 ; Sun et al, 2019 ), and hepatocellular cancers ( He et al, 2020 ). Over- or ectopic expression of SIX4 promoted metastasis by inducing epithelial-to-mesenchymal transition and angiogenesis ( Sun et al, 2019 ).…”
Section: Biomarkers and Prognostic Indicators In Cancermentioning
confidence: 99%
“…Over- or ectopic expression of SIX4 promoted metastasis by inducing epithelial-to-mesenchymal transition and angiogenesis ( Sun et al, 2019 ). Furthermore, significant correlations have been identified between expression levels of SIX4 , tumor cell metastasis, and poor patient prognosis ( Li et al, 2017 ; Tang et al, 2019 ; Sun et al, 2019 , 2020 ; He et al, 2020 ). To date, few studies have analyzed SIX5 function in cancer ( Table 2 ).…”
Section: Biomarkers and Prognostic Indicators In Cancermentioning
confidence: 99%
See 2 more Smart Citations